CloudMD Announces $10M Bought Deal

This evening CloudMD Software & Services Inc. (CSE: DOC) announced a $10M bought deal with a syndicate of underwriters co-led by Canaccord and Beacon. The underwriters agreed to purchase 14.3M units at a price of C$0.70 per unit with a full warrant priced at $1.00.

The stock has been on a role for the last month reaching a 52 week high of 95c.

The company also states they intend to use the proceeds of the offering for potential M&A activities to support their strategic growth plans and general corporate purposes.

The units will be offered by way of a short form prospectus and expected to close on June 2nd. The company granted the underwriters an option to purchase up to an additional 2.1M units at a price of C$0.70 per unit, exercisable at any time, for a period of 30 days after and including the closing date, which would result in additional proceeds of approximately C$1.5 million.

For full details, read the official company press release here.

The stock was halted all day and last traded at 77c.


FULL DISCLOSURE: CloudMD Software & Services is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover CloudMD Software & Services on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

CloudMD Telehealth Platform Increases Onboarding

CloudMD Software & Services (CSE: DOC) announced this morning that they are currently in the...

Monday, March 9, 2020, 07:52:56 AM

Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating

COVID-19 related stocks are all the rage this morning, however it appears to be for...

Monday, November 9, 2020, 10:56:07 AM

Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments

Revive Therapeutics (CSE: RVV) this morning announced that on the heels of receiving FDA approval...

Wednesday, August 5, 2020, 09:50:58 AM

Steven Mnuchin: Those Receiving $2 Million Or More Under PPP To Be Audited

As part of the CARES Act, the US federal government unveiled the Paycheck Protection Program...

Wednesday, April 29, 2020, 02:17:00 PM

Rebound in Oil Demand Remains at Risk of Coronavirus Resurgence

As the global demand for oil dried up significantly during the height of the pandemic,...

Sunday, July 12, 2020, 07:17:00 PM